These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11204290)

  • 1. Quinapril treatment enhances vascular sensitivity to insulin.
    Feldman RD; Schmidt ND
    J Hypertens; 2001 Jan; 19(1):113-8. PubMed ID: 11204290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinapril treatment restores the vasodilator action of insulin in fructose-hypertensive rats.
    Uchida T; Okumura K; Ito T; Kamiya H; Nishimoto Y; Yamada M; Tomida T; Matsui H; Hayakawa T
    Clin Exp Pharmacol Physiol; 2002; 29(5-6):381-5. PubMed ID: 12010179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.
    Dominguez LJ; Barbagallo M; Kattah W; Garcia D; Sowers JR
    Am J Hypertens; 1995 Aug; 8(8):808-14. PubMed ID: 7576397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin-dependent diabetes mellitus patients with hypertension. Swedish Quinapril Group.
    Ostman J; Asplund K; Bystedt T; Dahlöf B; Jern S; Kjellström T; Lithell H
    J Intern Med; 1998 Aug; 244(2):95-107. PubMed ID: 10095796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACE inhibitor versus beta-blocker for the treatment of hypertension in renal allograft recipients.
    Hausberg M; Barenbrock M; Hohage H; Müller S; Heidenreich S; Rahn KH
    Hypertension; 1999 Mar; 33(3):862-8. PubMed ID: 10082500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacodynamic responses of hypertensive patients to quinapril therapy.
    Fernandez PG; Snedden W
    Can J Cardiol; 1992 Mar; 8(2):189-94. PubMed ID: 1559192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of quinapril, atenolol, and verapamil on blood pressure and forearm hemodynamics during handgrip exercise.
    Cléroux J; Beaulieu M; Kouamé N; Lacourcière Y
    Am J Hypertens; 1994 Jun; 7(6):566-70. PubMed ID: 7917158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antihypertensive therapy on factors mediating endothelium-dependent relaxation in rats treated chronically with L-NAME.
    Maeso R; Navarro-Cid J; Rodrigo E; Ruilope LM; Cachofeiro V; Lahera V
    J Hypertens; 1999 Feb; 17(2):221-7. PubMed ID: 10067791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of quinapril, a new angiotensin-converting enzyme inhibitor, on vasoconstrictor activity in the isolated, perfused mesenteric vasculature of hypertensive rats.
    Major TC; Overhiser RW; Taylor DG; Panek RL
    J Pharmacol Exp Ther; 1993 Apr; 265(1):187-93. PubMed ID: 8474005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation by ACE inhibitor drugs of alpha-adrenoceptor sensitivity in human vessels: possible differences related to drug lipophilicity.
    Kimura M; Umemura K; Kosuge K; Nishimoto M; Ohashi K; Nakashima M
    Br J Clin Pharmacol; 1998 Dec; 46(6):599-603. PubMed ID: 9862250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled multicenter study with quinapril, hydrochlorothiazide, and combination in patients with moderate to severe hypertension.
    Romero R; Castellote E; Ocón J; Wagner B
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):114-8. PubMed ID: 7564350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular structure in the forearm and calf after 6 months of angiotensin converting enzyme inhibition in elderly hypertensive subjects with left ventricular hypertrophy.
    Marceau M; Kouamé N; Lacourcière Y; Cléroux J
    J Hypertens; 1998 May; 16(5):673-9. PubMed ID: 9797179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of angiotensin converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgery--a randomised study.
    Webb CM; Underwood R; Anagnostopoulos C; Bennett JG; Pepper J; Lincoln C; Collins P
    Eur J Cardiothorac Surg; 1998 Jan; 13(1):42-8. PubMed ID: 9504729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of smoking status on angiotensin-converting enzyme inhibition-related improvement in coronary endothelial function. TREND Investigators. Trial on Reversing Endothelial Dysfunction.
    Schlaifer JD; Mancini GB; O'Neill BJ; Pitt B; Haber HE; Pepine CJ
    Cardiovasc Drugs Ther; 1999 May; 13(3):201-9. PubMed ID: 10439882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin sensitivity, glucose effectiveness, and beta-cell function in obese males with essential hypertension: investigation of the effects of treatment with a calcium channel blocker (diltiazem) or an angiotensin-converting enzyme inhibitor (quinapril).
    Cabezas-Cerrato J; Garcia-Estevez DA; Araújo D; Iglesias M
    Metabolism; 1997 Feb; 46(2):173-8. PubMed ID: 9030825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tissue angiotensin-converting enzyme with quinapril reduces hypoxic pulmonary hypertension and pulmonary vascular remodeling.
    Nong Z; Stassen JM; Moons L; Collen D; Janssens S
    Circulation; 1996 Oct; 94(8):1941-7. PubMed ID: 8873672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the converting enzyme inhibitor quinapril (CI-906) on blood pressure, renin-angiotensin system, and prostanoids in essential hypertension.
    Säynävälammi P; Pörsti I; Pörsti P; Nurmi AK; Seppälä E; Manninen V; Vapaatalo H
    J Cardiovasc Pharmacol; 1988 Jul; 12(1):88-93. PubMed ID: 2459540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of quinapril and triamterene/hydrochlorothiazide on cardiac and vascular end-organ damage in isolated systolic hypertension.
    Heesen WF; Beltman FW; Smit AJ; May JF; de Graeff PA; Havinga TK; Schuurman FH; van der Veur E; Meyboom-de Jong B; Lie KI
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):187-94. PubMed ID: 9475259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors.
    Puig JG; Mateos FA; Ramos TH; Lavilla MP; Capitán MC; Gil A
    Am J Hypertens; 1994 Jan; 7(1):46-51. PubMed ID: 8136110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does blood pressure reduction necessarily compromise cardiac function or renal hemodynamics? Effects of the angiotensin-converting enzyme inhibitor quinapril.
    Kjeldsen SE; Gupta RK; Krause L; Weder AB; Julius S
    Am Heart J; 1992 May; 123(5):1433-8. PubMed ID: 1575171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.